Firefly Neuroscience granted 557,885 shares to Executive Chairman David Johnson

From Sabdrion Digital Marketintelligence: 2024-10-25 16:10:00

Firefly Neuroscience, Inc. announced the grant of 557,885 restricted shares to Executive Chairman David Johnson. The shares will vest in two parts, on the sixth and twelfth month anniversaries of the grant date, subject to Mr. Johnson’s continued service with the company. Firefly is developing Brain Network Analytics (BNA™) technology, which utilizes artificial intelligence to improve brain health outcomes for patients with various neurological and mental disorders. The company’s database of brain wave tests spans 15 years and over 17,000 patients, allowing for comprehensive insights into brain function for accurate diagnosis and treatment optimization.



Read more at Sabdrion Digital Marketintelligence: Firefly Neuroscience Announces Inducement Grant Under